Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients

BACKGROUND: CART therapy has produced a paradigm shift in the treatment of relapsing FL patients. Strategies to optimize disease surveillance after these therapies are increasingly necessary. This study explores the potential value of ctDNA monitoring with an innovative signature of personalized tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Ubieto, Ana, Martín-Muñoz, Alejandro, Poza, María, Dorado, Sara, García-Ortiz, Almudena, Revilla, Enrique, Sarandeses, Pilar, Ruiz-Heredia, Yanira, Baumann, Tycho, Rodríguez, Antonia, Calbacho, María, Sánchez, Pilar Martínez, Pina, José María Sánchez, García-Sancho, Alejandro Martín, Figaredo, Gloria, Rufián, Laura, Rodríguez, Margarita, Carneros, Laura, Martínez-Laperche, Carolina, Bastos-Oreiro, Mariana, Wang, Chongwu, Cedena, María-Teresa, Rapado, Inmaculada, de Toledo, Paula, Gallardo, Miguel, Valeri, Antonio, Ayala, Rosa, Martínez-López, Joaquín, Barrio, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277746/
https://www.ncbi.nlm.nih.gov/pubmed/37342332
http://dx.doi.org/10.3389/fimmu.2023.1188818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277746/
https://www.ncbi.nlm.nih.gov/pubmed/37342332
http://dx.doi.org/10.3389/fimmu.2023.1188818

Ejemplares similares